Ontology highlight
ABSTRACT: Purpose
Pediatric patients who undergo hematopoietic cell transplant (HCT) are at risk for neurocognitive impairments, which can impact quality of life. Given limited long-term studies, we aimed to characterize the late neurocognitive outcomes in a cohort of pediatric HCT survivors.Methods
Eligible survivors (HCT at age < 21 year and ≥ 1 year post-HCT) completed a 60-question survey of neurocognitive function and quality of life, which included the Childhood Cancer Survivor Study Neurocognitive Questionnaire (CCSS-NCQ) and the Neuro-Quality of Life Cognitive Function Short Form (Neuro-QoL). Analyses of risk factors included univariate comparisons and multivariable logistic regression.Results
Participants (n = 199, 50.3% female, 53.3% acute leukemia, 87.9% allogeneic
SUBMITTER: Wu NL
PROVIDER: S-EPMC8642486 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature